Come a long way, still a ways to go: from predicting and preventing fluoropyrimidine toxicity to increased efficacy?

Hamzic, Seid; Amstutz, Ursula; Largiadèr, Carlo Rodolfo (2018). Come a long way, still a ways to go: from predicting and preventing fluoropyrimidine toxicity to increased efficacy? Pharmacogenomics, 19(8), pp. 689-692. Future Medicine 10.2217/pgs-2018-0040

[img] Text
pgs-2018-0040.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (330kB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry

UniBE Contributor:

Hamzic, Seid; Amstutz, Ursula and Largiadèr, Carlo Rodolfo

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1462-2416

Publisher:

Future Medicine

Language:

English

Submitter:

Marie-Christine Müller

Date Deposited:

03 Apr 2019 12:37

Last Modified:

23 Oct 2019 16:57

Publisher DOI:

10.2217/pgs-2018-0040

PubMed ID:

29783877

Uncontrolled Keywords:

5-FU BSA-based dosing DPYD TDM capecitabine pharmacogenetics

BORIS DOI:

10.7892/boris.125805

URI:

https://boris.unibe.ch/id/eprint/125805

Actions (login required)

Edit item Edit item
Provide Feedback